CRO merger creates global firm with services across drug life cycle

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/travellinglight)
(Image: Getty/travellinglight)
Accelovance and Linical are merging to create a contract research organization (CRO) with a global footprint in response to the need for large-scale, multinational clinical trials.

Accelovance is a CRO focused on oncology, vaccine, dermatology, pain, nutrition, and women's health (Phase I-IV programs). The company this week announced its merger with Linical Co., Ltd., a Japan-headquartered CRO with global operations in more than 20 countries.

The transaction, terms of which were not disclosed, is scheduled to close early in the second quarter.

“This union creates a market-leading contract research organization with significant global scale across North America, Europe, and Asia Pacific,” ​said Alison Cundari, Accelovance marketing manager.

The companies expect little change to the operations of both entities, due to the complementary structure of both companies, explained Cundari.

The partnership expands the companies’ global footprint and strengthens offerings to cover “the entire drug life cycle”​ across several drug development areas, including oncology, immunology, and neurology.

“Over the coming months, we will continue to explore capabilities of the two organizations to create a high-performing, best-in-class leader in the clinical development space,”​ Cundari told Outsourcing-Pharma.com.

“This is an exciting milestone for both organizations,”​ she added. “Accelovance and Linical share a mission of delivering quality services to our clients and are committed to excellence in drug development.”

In the press release, Kazuhiro Hatano, Linical president and CEO said the deal will enable the company to “reinforce” ​its capabilities and capacity in the US, “as well as to strengthen our global network to respond to clients' needs of conducting large-scale multinational clinical trials.”

Related news

Show more

Related products

show more

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 01-Nov-2021 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Related suppliers

Follow us

Products

View more

Webinars